Text Size
18 studies found for:    alzheimer | bristol

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Avagacestat;   Drug: Placebo
2 Recruiting Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027;   Drug: Placebo matching BMS-241027
3 Completed A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163;   Drug: Placebo
4 Completed
Has Results 		Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
Condition: Dementia, Alzheimer Type
Interventions: Drug: Aripiprazole (BMS-337039);   Drug: Placebo
5 Completed Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
Condition: Alzheimer Disease
Intervention: Drug: aripiprazole
6 Completed Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
Condition: Alzheimer Disease
Intervention: Drug: aripiprazole
7 Completed Drug Interaction Study With a Potential Alzheimer's Disease Compound
Condition: Alzheimer Disease
Interventions: Drug: Interacting drugs - Cooperstown Cocktail (midazolam, warfarin, (+ vitamin K), caffeine, omeprazole and dextromethorphan);   Drug: BMS-708163;   Drug: BMS-708163 + Cooperstown Cocktail
8 Completed Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Healthy
Intervention: Drug: BMS-708163
9 Completed Drug-Drug Interaction Study With Aricept® (Donepezil)
Condition: Alzheimer Disease
Interventions: Drug: Donepezil;   Drug: BMS-708163
10 Completed Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: Placebo;   Drug: Moxifloxacin
11 Completed Multiple Dose Japanese Bridging Study
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: Placebo
12 Completed Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: BMS-708163 + Ketoconazole;   Drug: Ketoconazole;   Drug: Fluconazole;   Drug: BMS-708163 + Fluconazole
13 Completed Drug-Drug Interaction Study With Rifampin
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: Rifampin
14 Completed Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)
Condition: Alzheimer Disease
Interventions: Drug: galantamine;   Drug: BMS-708163
15 Completed Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163 (Gamma-Secretase Inhibitor);   Drug: Placebo matching BMS-708163
16 Completed Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
Conditions: Dementia;   Alzheimer's Disease
Interventions: Drug: Aripiprazole;   Drug: Placebo
17 Completed Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163
Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163;   Drug: Placebo
18 Active, not recruiting Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls
Conditions: Alzheimer Disease;   Progressive Supranuclear Palsy
Intervention:
To Top

† Indicates status has not been verified in more than two years